Creative Commons source reading · Nutrition and supplementation
Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review
Haifeng Geng; Zhibo Zhou; Lingfei Meng; Mingnan Zhuang; Yan Zhao
Originally published in Metabolites · 2026-07-08
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
Caffeine is among the most widely used supplements in sports nutrition, with substantial evidence supporting its efficacy for enhancing athletic performance. However, the relevance of pre-exercise caffeine supplementation extends beyond its ergogenic effects. Exercise itself acts as an acute cardiometabolic stressor, eliciting dynamic responses in blood pressure, heart rate, vascular tone, substrate utilization, and glucose regulation. Caffeine may further modify the magnitude, temporal profile, and recovery kinetics of these responses. This focused narrative review examines the acute cardiometabolic responses associated with pre-exercise caffeine supplementation and its potential regulatory effects. It outlines the underlying biological mechanisms, including adenosine receptor antagonism, hemodynamic and vascular pathways, and…
6. Translational Implications and Priorities for Future Research
Integrating mechanistic evidence with findings from human studies raises a practically important question: how should pre-exercise caffeine supplementation be balanced against the need to manage acute cardiometabolic burden? Current evidence suggests that, although the ergogenic effects of caffeine are well established, the acute cardiometabolic context in which these effects occur remains insufficiently characterized. Therefore, practical recommendations should not be based solely on exercise performance outcomes, but should also consider dose, individual cardiometabolic phenotype, and the differential responses elicited by different caffeine delivery forms.
6.1. Implications for Exercise Practice and Cardiometabolic Health
First, the ergogenic dose range does not fully overlap with the cardiometabolic safety window; therefore, practice-oriented recommendations should generally favor the lower end of the effective range. Previous studies [4,5,78] suggest that 3–6 mg·kg−1 is the most commonly used dose range for improving aerobic, high-intensity, and sport-specific performance, yet doses of approximately 2–3 mg·kg−1 may already produce observable ergogenic effects. By contrast, increasing the dose to ≥6 mg·kg−1 provides inconsistent additional benefits while increasing the risk of adverse effects. Moreover, acute elevations in blood pressure, impaired flow-mediated dilation, and delayed post-exercise autonomic recovery indicate that higher doses may impose a greater cardiometabolic burden [62]. For athletes with normal baseline cardiometabolic profiles,…
Editorial reading guide
- Was the outcome a biological marker, subjective response or meaningful performance change?
- What dose, timing, population and setting bound the practical conclusion?
